custom designed taqman single nucleotide genotyping assay (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
97
Structured Review
Thermo Fisher
custom designed taqman single nucleotide genotyping assay
Custom Designed Taqman Single Nucleotide Genotyping Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/custom+designed+taqman+single+nucleotide+genotyping+assay/PCR+NUCLEOTIDE/pm38523737-75-12-18
Average 97 stars, based on 1 article reviews
Custom Designed Taqman Single Nucleotide Genotyping Assay, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/custom+designed+taqman+single+nucleotide+genotyping+assay/PCR+NUCLEOTIDE/pm38523737-75-12-18
Average 97 stars, based on 1 article reviews
custom designed taqman single nucleotide genotyping assay - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Variant Assay:Article Title: 17-Beta-Hydroxysteroid Dehydrogenase 13 Loss of Function Does Not Confer Protection to Nonalcoholic Fatty Liver Disease in Indian Population. Article Snippet: 024 M A SL D Background:A splice variant inHSD17B13 gene is demonstrated to protect against nonalcoholic fatty liver disease (NAFLD), and mitigate the effect of Patatin-like phospholipase domain-containing 3 (PNPLA3-I148M).. It is being explored as a putative drug target and in polygenic risk scores.. Based on whole exome sequencing (WES) in our cohort of biopsy provenNAFLD and limited data on the variant in our ethnicity, we sought to explore its role. Genotyping Assay:Article Title: 17-Beta-Hydroxysteroid Dehydrogenase 13 Loss of Function Does Not Confer Protection to Nonalcoholic Fatty Liver Disease in Indian Population. Article Snippet: 024 M A SL D Background:A splice variant inHSD17B13 gene is demonstrated to protect against nonalcoholic fatty liver disease (NAFLD), and mitigate the effect of Patatin-like phospholipase domain-containing 3 (PNPLA3-I148M).. It is being explored as a putative drug target and in polygenic risk scores.. Based on whole exome sequencing (WES) in our cohort of biopsy provenNAFLD and limited data on the variant in our ethnicity, we sought to explore its role. Real-time Polymerase Chain Reaction:Article Title: 17-Beta-Hydroxysteroid Dehydrogenase 13 Loss of Function Does Not Confer Protection to Nonalcoholic Fatty Liver Disease in Indian Population. Article Snippet: 024 M A SL D Background:A splice variant inHSD17B13 gene is demonstrated to protect against nonalcoholic fatty liver disease (NAFLD), and mitigate the effect of Patatin-like phospholipase domain-containing 3 (PNPLA3-I148M).. It is being explored as a putative drug target and in polygenic risk scores.. Based on whole exome sequencing (WES) in our cohort of biopsy provenNAFLD and limited data on the variant in our ethnicity, we sought to explore its role. Polymerase Chain Reaction:Article Title: 17-Beta-Hydroxysteroid Dehydrogenase 13 Loss of Function Does Not Confer Protection to Nonalcoholic Fatty Liver Disease in Indian Population. Article Snippet: 024 M A SL D Background:A splice variant inHSD17B13 gene is demonstrated to protect against nonalcoholic fatty liver disease (NAFLD), and mitigate the effect of Patatin-like phospholipase domain-containing 3 (PNPLA3-I148M).. It is being explored as a putative drug target and in polygenic risk scores.. Based on whole exome sequencing (WES) in our cohort of biopsy provenNAFLD and limited data on the variant in our ethnicity, we sought to explore its role. |